Amal Therapeutics SA
Biotech developing unique therapeutic vaccines and a distinct unit of the Discovery Research organization of the Boehringer Ingelheim group of companies.
Our aim is to overcome the challenges around effective anti-cancer therapy by stimulating a patient’s immune system in a unique way, in order to create immunological memory, as well as target a broad range of patients.
Primary Therapeutic Areas
1.0 Therapeutic & Diagnostic
1.09 Proteins & Peptides